Related references
Note: Only part of the references are listed.Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-f31/Smad and MAPK signaling pathways
Jing Cui et al.
LIFE SCIENCES (2020)
Up-Regulation of Activating Transcription Factor 3 in Human Fibroblasts Inhibits Melanoma Cell Growth and Migration Through a Paracrine Pathway
Tingjian Zu et al.
FRONTIERS IN ONCOLOGY (2020)
Epigenetic modification mechanisms involved in keloid: current status and prospect
Wenchang Lv et al.
CLINICAL EPIGENETICS (2020)
Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial
Farrukh Aslam Khalid et al.
BURNS (2019)
Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1
Yuichi Akatsu et al.
MOLECULAR ONCOLOGY (2019)
Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3)
Chaochen Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways
Rui Lei et al.
CELL CYCLE (2019)
Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice
Z. Wang et al.
ONCOGENE (2018)
Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids
Ho Jun Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer
Mohamed S. Hasim et al.
TRANSLATIONAL ONCOLOGY (2018)
Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target
Heng Zhou et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
Cardiac Fibroblast-Specific Activating Transcription Factor 3 Promotes Myocardial Repair after Myocardial Infarction
Yu-Lin Li et al.
CHINESE MEDICAL JOURNAL (2018)
Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions
M. Rohini et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase
Anna Vert et al.
ONCOTARGET (2017)
Activating transcription factor 3 (ATF3) protects against lipopolysaccharide-induced acute lung injury via inhibiting the expression of TL1A
Lanlan Qian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation
Dong Eun Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
ATF3 promotes migration and M1/M2 polarization of macrophages by activating tenascin-C via Wnt/β-catenin pathway
Hao Sha et al.
MOLECULAR MEDICINE REPORTS (2017)
From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
Avi Ashkenazi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Evidence of invasive and noninvasive treatment modalities for hypertrophic scars: A systematic review
Mona Kafka et al.
WOUND REPAIR AND REGENERATION (2017)
Activating transcription factor 3 promotes malignance of lung cancer cells in vitro
Xuebing Li et al.
THORACIC CANCER (2017)
Letter by Li et al Regarding Article, Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling
Yangxin Li et al.
CIRCULATION (2017)
DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway
Yang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Camel Whey Protein Protects B and T Cells from Apoptosis by Suppressing Activating Transcription Factor-3 (ATF-3)-Mediated Oxidative Stress and Enhancing Phosphorylation of AKT and IκB-α in Type I Diabetic Mice
Gamal Badr et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
Tatjana Mallano et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κB
Ji-Woong Kwon et al.
SCIENTIFIC REPORTS (2015)
Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy
Lalita Yadav et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Endoglin Promotes TGF-β/Smad1 Signaling in Scleroderma Fibroblasts
Erin Morris et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Role of transforming growth factor-beta superfamily signaling pathways in human disease
Kelly J. Gordon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Transforming growth factor-β1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture
R. Naim et al.
AESTHETIC PLASTIC SURGERY (2008)
Share Paper
